EXANE DERIVATIVES - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$26,525,000
-75.6%
40,660
-10.1%
0.01%
-72.0%
Q2 2021$108,542,000
-33.3%
45,2270.0%0.02%
-46.8%
Q1 2021$162,810,000
+475.7%
45,227
+303.0%
0.05%
+487.5%
Q4 2020$28,281,00011,2230.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders